Life sciences advisory for private capital investors.
Life sciences advisory for private capital investors.
Life sciences advisory for private capital investors.
Integrated support for confident investment decisions.
Integrated support for confident investment decisions.
Integrated support for confident investment decisions.
Life Sciences Experts
1000+
Therapeutic Programmes Assessed
Drug Development Specialists
40+
Indications Covered Across US, EU & APAC
Run by Investors & Operators
Expertise across all stages of R&D
Run by Investors & Operators
Expertise across all stages of drug development
Life Sciences Experts
1000+
Therapeutic Programmes Assessed
Drug Development Specialists
40+
Indications Covered Across US, EU & APAC
Run by Investors & Operators
Expertise across all stages of R&D
Run by Investors & Operators
Expertise across all stages of drug development
Life Sciences Experts
1000+
Therapeutic Programmes Assessed
Drug Development Specialists
40+
Indications Covered
Run by Investors & Operators
Expertise across all stages of R&D
Run by Investors & Operators
Expertise across all stages of drug development
We translate complex biology into clear investment logic.
Acuity Bio delivers the scientific depth of an internal research team and the financing judgment of an experienced biotech venture partner.
We translate complex biology into clear investment logic.
Why investors choose Acuity Bio
Here is why specialist investors trust Acuity Bio to deliver precise, actionable diligence
Generalist Advisors
Surface-level analysis lacking scientific insight
Diligence checklists that miss biotech-specific risks
Impractical reports difficult for committees to digest
Slow turnarounds and rigid engagement
Priced beyond the needs of smaller investors
Surface-level analysis lacking scientific insight
Diligence checklists that miss biotech-specific risks
Impractical reports difficult for committees to digest
Slow turnarounds and rigid engagement
Priced beyond the needs of smaller investors
Specialist experience in biotech venture investing
Tailored risk reviews with technical red flags
Decision-ready reports designed for non-specialists
Flexible engagements tailored to each client
Affordable pricing matching boutique budgets
Specialist experience in biotech venture investing
Tailored risk reviews with technical red flags
Decision-ready reports designed for non-specialists
Flexible engagements tailored to each client
Affordable pricing matching boutique budgets
What we offer
Comprehensive solutions for business success.
Investment Due Diligence
In-depth assessment of investment opportunities across biotech, techbio, devices and medtech.
Investment Due Diligence
In-depth assessment of investment opportunities across biotech, techbio, devices and medtech.
Venture Perspective
Practical commentary on valuation realism, dilution, next-round scenarios and exit potential.
Business Solutions
Practical commentary on valuation realism, dilution, next-round scenarios and exit potential.
Early Stage Risk Review
Operational and development plan challenges frequently overlooked by non-specialists.
Early Stage Risk Review
Operational and development plan challenges frequently overlooked by non-specialists.
IC Ready Outputs
Reports that investment committees can read and understand in minutes.
IC Ready Outputs
Reports that investment committees can read and understand in minutes.
On-Demand Engagement
Use us only when a life science opportunity appears.
On-Demand Engagement
Use us only when a life science opportunity appears.
Transparent Fees & Timelines
Fixed prices, on-time delivery promise and no open-ended consulting bills.
Transparent Fees & Timelines
Fixed prices, on-time delivery promise and no open-ended consulting bills.
What we offer
Acuity Bio delivers the scientific depth of an internal research team and the financing judgment of an experienced biotech venture partner.
Investment Due Diligence
In-depth assessment of investment opportunities across biotech, techbio, devices and medtech.
Venture Perspective
Practical commentary on valuation realism, dilution, next-round scenarios and exit potential.
Early Stage Risk Review
Operational and development plan challenges frequently overlooked by non-specialists.
IC Ready Outputs
Reports that investment committees can read and understand in minutes.
On-Demand Engagement
Use us only when a life science opportunity appears.
Transparent Fees & Timelines
Fixed prices, on-time delivery promise and no open-ended consulting bills.
Pricing
We offer three packages to suit your specific needs
Initial Screening
$2,499
per project
Independent red-flag check
Core science & operational risks
Brief IC-ready summary memo
30-min investor meeting
Clear go / refine / stop output
Diligence
$4,999
per project
Comprehensive diligence
Competitive & exit context
Detailed IC report & risk register
Q&A debrief & follow-up support
Clear go / refine / stop output
On-Call Support
On Request
per month
Flexible monthly capacity
Priority deal screening anytime
Rolling support for live deals
Fixed fees
Clear time commitment
Initial Screening
$2,499
per project
Independent red-flag check
Core science & operational risks
Brief IC-ready summary memo
30-min investor meeting
Clear go / refine / stop output
Diligence
$4,999
per project
Comprehensive diligence
Competitive & exit context
Detailed IC report & risk register
Q&A debrief & follow-up support
Clear go / refine / stop output
On-Call Support
On Request
per month
Flexible monthly capacity
Priority deal screening anytime
Rolling support for live deals
Fixed fees
Clear time commitment
How our work adds real value
Short anonymised case studies to showcase where Acuity's work will add value for your firm.
Family office investor did not have internal expertise to conduct diligence of an advanced therapeutic company. Acuity Bio delivered a scientific diligence report used in the investment committee.
Outcome:
Deal confience increased
Family office investor did not have internal expertise to conduct diligence of an advanced therapeutic company. Acuity Bio delivered a scientific diligence report used in the investment committee.
Outcome:
Deal confience increased
Acuity Bio's diligence report enabled a generalist VC fund to make a clear decline decision within 72 hours, saving time and legal fees on a weak asset. Acuity Bio was retained for quick triage of similar opportunities thereafter.
Outcome:
Faster go/no-go decision
Acuity Bio's diligence report enabled a generalist VC fund to make a clear decline decision within 72 hours, saving time and legal fees on a weak asset. Acuity Bio was retained for quick triage of similar opportunities thereafter.
Outcome:
Faster go/no-go decision
A European family office avoided a costly term sheet after we uncovered a key manufacturing risk not disclosed in the deck.
Outcome:
Key R&D risk flagged
A European family office avoided a costly term sheet after we uncovered a key manufacturing risk not disclosed in the deck.
Outcome:
Key R&D risk flagged
A corporate VC team used our clear, sourced memorandum to secure internal buy-in for a $25m Series A round.
Outcome:
Board approval secured
A corporate VC team used our clear, sourced memorandum to secure internal buy-in for a $25m Series A round.
Outcome:
Board approval secured
Family office investor did not have internal expertise to conduct diligence of an advanced therapeutic company. Acuity Bio delivered a scientific diligence report used in the investment committee.
Outcome:
Deal confience increased
Acuity Bio's diligence report enabled a generalist VC fund to make a clear decline decision within 72 hours, saving time and legal fees on a weak asset. Acuity Bio was retained for quick triage of similar opportunities thereafter.
Outcome:
Faster go/no-go decision
A European family office avoided a costly term sheet after we uncovered a key manufacturing risk not disclosed in the deck.
Outcome:
Key R&D risk flagged
A corporate VC team used our clear, sourced memorandum to secure internal buy-in for a $25m Series A round.
Outcome:
Board approval secured
Frequently Asked Questions
Clear answers about how our specialist diligence helps you invest with confidence.
How does your approach differ from other advisors?
What kinds of investors use your services?
What is included in a typical report?
How long does a typical review take?
Is your pricing fixed or flexible?
How do we start working with you?
Do you stay involved after the report is delivered?
Frequently Asked Questions
Clear answers about how our specialist diligence helps you invest with confidence.
How does your approach differ from other advisors?
What kinds of investors use your services?
What is included in a typical report?
How long does a typical review take?
Is your pricing fixed or flexible?
How do we start working with you?
Do you stay involved after the report is delivered?
Frequently Asked Questions
Clear answers about how our specialist diligence helps you invest with confidence.
How does your approach differ from other advisors?
What kinds of investors use your services?
What is included in a typical report?
How long does a typical review take?
Is your pricing fixed or flexible?
How do we start working with you?
Do you stay involved after the report is delivered?
Ready to make confident biotech investment decisions?
Engage our specialist team for clear, independent diligence exactly when you need it.
Ready to make confident biotech investment decisions?
Engage our specialist team for clear, independent diligence exactly when you need it.
Ready to make confident biotech investment decisions?
Engage our specialist team for clear, independent diligence exactly when you need it.